blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0528762

EP0528762 - N-acyl-N-heterocyclyl- or naphthyl-alkyl amino acids as angiotensin II antagonists [Right-click to bookmark this link]
Former [1993/08]N-acyl-N-heterocyclyl- or naphtalenyl-alkyl amino acids as angiotensin II antagonists
[1997/19]
StatusNo opposition filed within time limit
Status updated on  13.03.1998
Database last updated on 02.11.2024
Most recent event   Tooltip13.03.1998No opposition filed within time limitpublished on 29.04.1998 [1998/18]
Applicant(s)For all designated states
Novartis AG
Schwarzwaldallee 215
4058 Basel / CH
[1997/14]
Former [1993/08]For all designated states
CIBA-GEIGY AG
Klybeckstrasse 141
CH-4002 Basel / CH
Inventor(s)01 / Schmidlin, Tibur, Dr.
Friedensgasse 36
CH-4056 Basel / CH
02 / Zbinden, Paul
Rainacker 6
CH-4108 Witterswil / CH
03 / Bühlmayer, Peter, Dr.
Hangstrasse 18
CH-4144 Arlesheim / CH
[1993/08]
Application number, filing date92810603.806.08.1992
[1993/08]
Priority number, dateCH1991000240515.08.1991         Original published format: CH 240591
CH1992000037507.02.1992         Original published format: CH 37592
CH1992000114108.04.1992         Original published format: CH 114192
[1993/08]
Filing languageDE
Procedural languageDE
PublicationType: A1 Application with search report 
No.:EP0528762
Date:24.02.1993
Language:DE
[1993/08]
Type: B1 Patent specification 
No.:EP0528762
Date:07.05.1997
Language:DE
[1997/19]
Search report(s)(Supplementary) European search report - dispatched on:EP23.11.1992
ClassificationIPC:C07D401/10, A61K31/33, C07D409/10, C07D407/10, C07D333/60, C07D257/04
[1993/08]
CPC:
C07D257/04 (EP,US); C07D401/10 (EP,KR,US); A61P27/02 (EP);
A61P27/06 (EP); A61P9/00 (EP); A61P9/10 (EP);
A61P9/12 (EP); C07D215/12 (EP,US); C07D217/14 (EP,US);
C07D333/60 (EP,US); C07D405/10 (EP,US); C07D409/10 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   NL,   PT,   SE [1993/08]
TitleGerman:N-Acyl-N-Heterocyclyl- oder Naphthylalkyl-Aminosäuren als Angiotensin II Antagonisten[1997/19]
English:N-acyl-N-heterocyclyl- or naphthyl-alkyl amino acids as angiotensin II antagonists[1997/19]
French:Acides aminés N-acyl-N-hétérocyclyl- ou naphtyl-alkyl comme angiotensine II antagonistes[1997/19]
Former [1993/08]N-Acyl-N-heterocyclyl- oder naphtalenyl-alkyl-aminosäuren als Angiotensin II Antagoniste
Former [1993/08]N-acyl-N-heterocyclyl- or naphtalenyl-alkyl amino acids as angiotensin II antagonists
Former [1993/08]Acides aminés N-acyl-N-hétérocyclyl- ou napthalényl-alkyl comme angiotensine II antagonistes
Examination procedure25.06.1993Examination requested  [1993/34]
02.07.1996Despatch of communication of intention to grant (Approval: No)
28.10.1996Despatch of communication of intention to grant (Approval: later approval)
05.11.1996Communication of intention to grant the patent
23.01.1997Fee for grant paid
23.01.1997Fee for publishing/printing paid
Opposition(s)10.02.1998No opposition filed within time limit [1998/18]
Fees paidRenewal fee
05.07.1994Renewal fee patent year 03
30.06.1995Renewal fee patent year 04
26.06.1996Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]EP0429257  (GLAXO GROUP LTD [GB]);
 [A]EP0434249  (GLAXO GROUP LTD [GB]);
 [AP]EP0443983  (CIBA GEIGY AG [CH]);
 [AP]EP0490820  (CIBA GEIGY AG [CH])
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.